NEW YORK, April 19 - Lexicon Genetics unveiled a new plan Thursday to determine the in vivo function of 1,000 genes per year for the next five years.

The company plans to find the functions of 5,000 genes, approximately the number of drug targets many scientists believe are encoded in the human genome by 2006, Arthur Sands, Lexicon's CEO, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.